Skip to main content
. 2020 May 4;7(5):722–732. doi: 10.1002/acn3.51035

Figure 3.

Figure 3

Proportion of patients and controls allocated to each biomarker stage by maximum likelihood. The stages are in the same order as given in Figure 2A.